The European Union has quietly tightened fragrance allergen labeling rules, and the deadline is less than two weeks away. Starting July 31, 2026, every cosmetic product sold in the EU must declare roughly 80 fragrance allergens on its label, up from the previous 24. A correction published in late 2025 also modified three specific ingredients, forcing brands to update packaging they may have already finalized.

Why Did the EU Expand the Fragrance Allergen List?

The European Commission expanded the allergen disclosure requirement based on research from the Scientific Committee on Consumer Safety (SCCS), which identified 56 additional substances that have clearly caused allergies in humans but were not previously required to be labeled individually. These include common fragrance components like linalool, limonene, geraniol, citronellol, eugenol, and citral. The goal is transparency: consumers with fragrance sensitivities can now identify problematic ingredients before purchase.

The expanded list matters because many of these allergens occur naturally in essential oils widely used across the cosmetics industry. Lavender oil, citrus oils, rose oils, bergamot, and eucalyptus all contain measurable concentrations of these substances. A single fragrance composition using three or four essential oils can easily exceed the labeling threshold for multiple allergens simultaneously, making supplier disclosures critical.

What Changed in the November 2025 Correction?

A Corrigendum published in November 2025 made three operationally significant changes to the original 2023 regulation, with no change to the July 31 deadline. Brands that finalized artwork against the original text must now retrofit their labels before the cutoff.

• Rose Ketone INCI Name: The original entry was replaced with "Rose ketone 4 (Damascenone)" to ensure accurate identification. Labels carrying the old name must be updated.
• Pelargonium Graveolens Scope Expanded: The entry now covers oil, flower oil, and leaf oil separately. Each must be declared individually when above threshold, affecting brands working with rose geranium essential oils.
• Patchouli Added to List: Pogostemon Cablin Leaf Oil (patchouli leaf oil) is now a required allergen disclosure, with both oil and leaf oil variants requiring individual labeling.

How to Prepare for the July 31 Deadline?

Cosmetics teams managing this transition effectively are following a five-step action plan, with the highest-leverage step first.

• Request Fresh Allergen Disclosures: Contact every fragrance and essential oil supplier for updated declarations analyzed against the expanded 80-substance list, not the old 24. This is the single most critical step.
• Verify Grouping Rules: Some allergens are grouped under a single common name (for example, Citral, Geranial, and Neral all labeled as CITRAL). Verify each substance against the regulation to ensure correct labeling.
• Coordinate with Glossary Updates: The EU Common Ingredients Glossary becomes mandatory on July 30, 2026, adding 348 new ingredient entries. Artwork updated for fragrance allergens after this date should also reflect the new Glossary terminology to avoid a second round of updates.
• Manage Multilingual Consistency: Cosmetic products are placed on labels in 24 EU official languages plus regional variants. Fragrance allergen INCI names are standardized, but surrounding ingredient lists and warnings must be consistent across every language version to avoid compliance drift under deadline pressure.
• Plan Staging Around Key Dates: July 30 marks the Glossary update; July 31 is the compliance deadline for new products; July 31, 2028, is the clearance deadline for existing stock placed on the market before July 31, 2026.

Teams that started planning in 2024 are now in the finalization phase. Those still in planning mode have approximately ten weeks to complete the work. Canada is phasing in similar requirements based on the same SCCS-identified substances, so brands selling into both markets are coordinating a single artwork update wave rather than running separate compliance cycles.

The complexity of this transition reflects a broader shift in cosmetics regulation toward ingredient transparency, particularly for substances that trigger allergic reactions. For consumers, the expanded labeling means better access to information about fragrance components that may cause sensitivity or irritation. For brands, it means a significant operational lift before the deadline arrives.